BR112017020511A2 - ?composição de emplastro de microagulha, e, método para tratar uma condição de pele?. - Google Patents

?composição de emplastro de microagulha, e, método para tratar uma condição de pele?.

Info

Publication number
BR112017020511A2
BR112017020511A2 BR112017020511A BR112017020511A BR112017020511A2 BR 112017020511 A2 BR112017020511 A2 BR 112017020511A2 BR 112017020511 A BR112017020511 A BR 112017020511A BR 112017020511 A BR112017020511 A BR 112017020511A BR 112017020511 A2 BR112017020511 A2 BR 112017020511A2
Authority
BR
Brazil
Prior art keywords
microneedle
microneedles
patch composition
treating
microneedle patch
Prior art date
Application number
BR112017020511A
Other languages
English (en)
Portuguese (pt)
Inventor
Crean Abina
Huss ERIKSSON André
MOORE Anne
O'sullivan Caroline
Jansson Jörgen
Margrethe ENGELL Karen
Petersson Karsten
Troensegaard NIELSEN Kim
Vucen Sonja
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of BR112017020511A2 publication Critical patent/BR112017020511A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046—Solid microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053—Methods for producing microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112017020511A 2015-03-27 2016-03-16 ?composição de emplastro de microagulha, e, método para tratar uma condição de pele?. BR112017020511A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15161262 2015-03-27
EP15176101 2015-07-09
PCT/EP2016/025026 WO2016155891A1 (en) 2015-03-27 2016-03-16 Microneedle patch for delivering an active ingredient to skin

Publications (1)

Publication Number Publication Date
BR112017020511A2 true BR112017020511A2 (pt) 2018-07-10

Family

ID=55910913

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017020511A BR112017020511A2 (pt) 2015-03-27 2016-03-16 ?composição de emplastro de microagulha, e, método para tratar uma condição de pele?.

Country Status (20)

Country Link
US (2) US20180078498A1 (cg-RX-API-DMAC7.html)
EP (1) EP3273942B1 (cg-RX-API-DMAC7.html)
JP (1) JP6929784B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170131642A (cg-RX-API-DMAC7.html)
CN (1) CN107405301B (cg-RX-API-DMAC7.html)
AU (1) AU2016239277B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017020511A2 (cg-RX-API-DMAC7.html)
CA (1) CA2979435A1 (cg-RX-API-DMAC7.html)
DK (1) DK3273942T3 (cg-RX-API-DMAC7.html)
ES (1) ES2886129T3 (cg-RX-API-DMAC7.html)
HK (1) HK1246208A1 (cg-RX-API-DMAC7.html)
IL (1) IL254183A0 (cg-RX-API-DMAC7.html)
MA (1) MA41818A (cg-RX-API-DMAC7.html)
MX (1) MX382471B (cg-RX-API-DMAC7.html)
MY (1) MY191513A (cg-RX-API-DMAC7.html)
PL (1) PL3273942T3 (cg-RX-API-DMAC7.html)
SG (1) SG11201707141TA (cg-RX-API-DMAC7.html)
UA (1) UA124141C2 (cg-RX-API-DMAC7.html)
WO (1) WO2016155891A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA201706259B (cg-RX-API-DMAC7.html)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015164840A1 (en) 2014-04-24 2015-10-29 Georgia Tech Research Corporation Microneedles and methods of manufacture thereof
CA3238290A1 (en) 2015-04-17 2016-10-20 Georgia Tech Research Corporation Drug delivery device with housing and separable microneedles
US20170348218A1 (en) * 2016-06-03 2017-12-07 Sanova Bioscience Inc Microneedle patch containing hyaluronic acid for cosmetic use
EP3582752A1 (en) * 2017-02-17 2019-12-25 Allergan, Inc. Microneedle array with active ingredient
AU2018309562A1 (en) * 2017-08-04 2020-02-20 Vaxxas Pty Limited Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (MAP)
EP4691539A3 (en) * 2017-10-11 2026-04-22 Georgia Tech Research Corporation Separable microneedle arrays for sustained release of drug
SG10201800072YA (en) * 2018-01-03 2019-08-27 Micropoint Tech Pte Ltd Microneedle Patches Comprising Corticosteroid
KR102094744B1 (ko) * 2018-01-26 2020-03-30 가천대학교 산학협력단 마이크로 니들 및 이의 제조방법
US11045187B2 (en) 2018-02-28 2021-06-29 BandGrip, Inc. Subcutaneous wound closure assembly and method of use
KR20200144124A (ko) * 2018-04-13 2020-12-28 노쓰 캐롤라이나 스테이트 유니버시티 여드름 치료용 ros-반응성 미세바늘 패치
KR102146704B1 (ko) * 2018-04-13 2020-08-21 가천대학교 산학협력단 사이클로스포린 A (CsA) 경피 및 피내 약물전달용 마이크로구조체
US12121618B2 (en) 2018-05-18 2024-10-22 Postech Academy-Industry Foundation Transdermal drug delivery patch and manufacturing method thereof
CN112423829B (zh) * 2018-05-18 2023-03-28 浦项工科大学校产学协力团 经皮药物递送贴剂及其制造方法
CN108721204A (zh) * 2018-06-04 2018-11-02 南京紫源康医药科技有限公司 一种可溶性紫草素微针贴片及其制备方法
CN108703895B (zh) * 2018-08-21 2021-02-09 广州香蒲兰电子商务有限公司 一种深层渗透的长效保湿凝胶及制备方法
CN110917176B (zh) * 2018-08-31 2021-03-30 中科微针(北京)科技有限公司 一种可植入型缓释微针贴片及其制备方法
CN110870846A (zh) * 2018-08-31 2020-03-10 中科微针(北京)科技有限公司 一种可快速植入型缓释微针贴片及其制备方法
CN108888577B (zh) * 2018-09-11 2021-09-14 无锡元旭生物技术有限公司 一种可溶性玻尿酸美容微针贴及其制备方法
US12465736B2 (en) * 2018-09-24 2025-11-11 L'oreal Device comprising microneedles for in-situ reaction of a skin
JP7666887B2 (ja) * 2018-12-21 2025-04-22 ロレアル マイクロニードルシートを使用するキット及び美容方法
GB201908229D0 (en) 2019-06-10 2019-07-24 Univ College Cork National Univ Of Ireland Microneedles and methods for the manufacture thereof
ES2966108T3 (es) 2019-07-10 2024-04-18 Mineed Tech Company Limited Microaguja soluble
CN114761054B (zh) * 2019-10-22 2025-07-15 佐治亚科技研究公司 利用浇铸制剂中的组分溶解度的调整来制作微针的方法
US20230073125A1 (en) * 2019-10-29 2023-03-09 The Regents Of The University Of California Periodontal micropatch and uses thereof
EP4061334A4 (en) * 2019-11-22 2024-02-14 Veradermics Incorporated MICRONEEDLE PATCH FOR THE ADMINISTRATION OF IMMUNO-STIMULATING MEDICATIONS
WO2021119332A1 (en) * 2019-12-11 2021-06-17 The Regents Of The University Of California Microneedle delivery device with detachable hybrid microneedle depots for localized delivery of cells
WO2021221973A1 (en) 2020-04-28 2021-11-04 Ticona Llc Microneedle assembly
CA3189066A1 (en) * 2020-07-06 2022-01-13 Kindeva Drug Delivery L.P. Drug delivery device including patch segments
NL2026264B1 (en) 2020-08-13 2022-04-13 Versailles B V Microneedle applicator with active ingredient for treatment of skin lesions
HU231600B1 (hu) 2020-09-18 2025-03-28 Semmelweis Egyetem 40% Bőrtapasz a SARS-CoV-2 vírusfertőzöttség elleni immunvédettség celluláris diagnosztikai vizsgálatához
CN112294750B (zh) * 2020-10-29 2023-06-20 广东药科大学 一种吲哚美辛胶束复合微针及其制备方法
CN112516449B (zh) * 2020-12-03 2023-02-21 昆明理工大学 一种可溶性微针阵列及其制备方法
CA3212891A1 (en) * 2021-03-23 2022-09-29 Veradermics Incorporated Perilesional treatment of skin conditions
KR102778469B1 (ko) * 2021-04-12 2025-03-11 한미약품 주식회사 마이크로니들 어레이 및 이의 제조방법
US20240261552A1 (en) * 2021-05-21 2024-08-08 Veradermics Incorporated Microneedle patch for immunostimulatory drug delivery
CN115581659A (zh) * 2021-07-05 2023-01-10 刘野 一种非甾体类抗炎药微针及其制备方法
WO2023014375A1 (en) * 2021-08-06 2023-02-09 Lean Life Sciences, Inc Cosmetic peptides for improving skin rejuvenation
KR20230129639A (ko) * 2022-03-02 2023-09-11 연세대학교 산학협력단 이중작용 pde5 억제제/질산유기에스터의 국소 혈류 증진을 위한 경피 투약 형태
US20260021036A1 (en) * 2022-04-07 2026-01-22 Sheba Impact Ltd. Flexible biodegradable microneedles
WO2023218230A1 (en) * 2022-05-13 2023-11-16 Mineed Technology Company Limited Dissolvable microneedle patch
CN115317439A (zh) * 2022-07-18 2022-11-11 合肥博思科创医药科技有限公司 一种克立硼罗微针贴剂及其制备方法
CN116115552B (zh) * 2023-01-06 2025-01-17 山东第二医科大学 一种托法替布纳米微针制剂及其制备方法和应用
CN116421874A (zh) * 2023-04-11 2023-07-14 上海交通大学医学院附属第九人民医院 一种载抗血管瘤药物可溶微针贴片及其制备方法
CN121443348A (zh) * 2023-06-21 2026-01-30 徐硕培 利用激光的药物注入用针贴片
US20250114579A1 (en) * 2023-10-09 2025-04-10 Beihang University Drug delivery system, and preparation method and use method thereof
CN117883362A (zh) * 2024-01-17 2024-04-16 中国医学科学院生物医学工程研究所 一种装载富马酸二甲酯的调节性t细胞外泌体微针及其制备方法与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39706E1 (en) 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
CN1173703C (zh) * 1999-04-23 2004-11-03 里奥药物制品有限公司 药物组合物
AU2001296828B2 (en) 2000-10-13 2005-11-24 Alza Corporation Apparatus and method for piercing skin with microprotrusions
US9302903B2 (en) 2000-12-14 2016-04-05 Georgia Tech Research Corporation Microneedle devices and production thereof
US6893431B2 (en) * 2001-10-15 2005-05-17 Scimed Life Systems, Inc. Medical device for delivering patches
WO2006055799A1 (en) * 2004-11-18 2006-05-26 3M Innovative Properties Company Masking method for coating a microneedle array
US7651946B2 (en) 2005-12-12 2010-01-26 University College Cork - National University Of Ireland, Cork Wet etch processing
CN1857730B (zh) * 2006-03-30 2010-05-12 西安交通大学 带微孔的多腔体可降解植入式药物控释载体及其制备工艺
US20090182306A1 (en) * 2006-07-21 2009-07-16 Georgia Tech Research Corporation Microneedle Devices and Methods of Drug Delivery or Fluid Withdrawal
JP5553612B2 (ja) 2007-01-22 2014-07-16 コリウム インターナショナル, インコーポレイテッド マイクロニードルアレイ用アプリケータ
EP2139492A1 (en) * 2007-03-30 2010-01-06 Fovea Pharmaceuticals SA Methods for treating neovascular ocular diseases
AU2014200648B2 (en) * 2007-04-16 2015-09-24 Corium Pharma Solutions, Inc. Solvent-cast microneedle arrays containing active
WO2008130587A2 (en) 2007-04-16 2008-10-30 Corium International, Inc. Solvent-cast microneedle arrays containing active
KR101634836B1 (ko) * 2008-12-26 2016-06-29 히사미쓰 세이야꾸 가부시키가이샤 마이크로 니들 디바이스
JP6327852B2 (ja) * 2010-05-04 2018-05-23 コリウム インターナショナル, インコーポレイテッド 微小突起アレイを使用した副甲状腺ホルモンの経皮送達のための方法及びデバイス
GB201019577D0 (en) 2010-11-18 2010-12-29 Univ Cork Method
GB201107642D0 (en) 2011-05-09 2011-06-22 Univ Cork Method
CN104027324B (zh) * 2013-03-06 2017-12-15 中国科学院理化技术研究所 一种可溶性微针疫苗贴片及其制备方法
AU2014233695A1 (en) * 2013-03-15 2015-10-01 Corium International, Inc. Microarray for delivery of therapeutic agent and methods of use
JP6370296B2 (ja) * 2013-07-30 2018-08-08 Asti株式会社 マイクロニードルアレイとマイクロニードルアレイ製造方法
US20150057505A1 (en) * 2013-08-22 2015-02-26 Elwha Llc Method for Administering a Medicament to a Fetus

Also Published As

Publication number Publication date
ES2886129T3 (es) 2021-12-16
MX382471B (es) 2025-03-13
JP2018510170A (ja) 2018-04-12
HK1246208A1 (zh) 2018-09-07
CA2979435A1 (en) 2016-10-06
US20230404909A1 (en) 2023-12-21
RU2017134576A3 (cg-RX-API-DMAC7.html) 2019-08-27
AU2016239277B2 (en) 2019-01-24
WO2016155891A1 (en) 2016-10-06
US20180078498A1 (en) 2018-03-22
PL3273942T3 (pl) 2021-12-06
CN107405301A (zh) 2017-11-28
ZA201806163B (en) 2019-12-18
IL254183A0 (en) 2017-10-31
MX2017012321A (es) 2018-01-18
SG11201707141TA (en) 2017-10-30
UA124141C2 (uk) 2021-07-28
ZA201706259B (en) 2018-12-19
DK3273942T3 (da) 2021-09-13
EP3273942A1 (en) 2018-01-31
RU2017134576A (ru) 2019-04-04
MY191513A (en) 2022-06-28
KR20170131642A (ko) 2017-11-29
JP6929784B2 (ja) 2021-09-01
AU2016239277A1 (en) 2017-09-28
EP3273942B1 (en) 2021-06-16
MA41818A (fr) 2018-01-30
CN107405301B (zh) 2021-11-30

Similar Documents

Publication Publication Date Title
MX2017012321A (es) Parche de microagujas para administrar un ingrediente activo a la piel.
BR112018073703A2 (pt) emplastro para pele ou ferida, composição farmacêutica e método para a liberação de uma substância ativa
BR112015022432A8 (pt) arranjo de microestrutura e método de fabricação de um arranjo de microestrutura
BR112014019233A8 (pt) Emplastros medicinais para criar ou manter uma área de tecido humano livre de contaminantes
BR112016028961A2 (pt) composições compreendendo fibras obtidas por via eletro-hidrodinâmica para administração de dosagens específicas de uma substância ativa à pele ou mucosa
BR112015019440A2 (pt) métodos e dispositivos para fortalecimento da pele
MX387061B (es) Formulación farmacéutica en aerosol formadora de película polimérica que comprende un agente activo y povidona como agente inhibidor de la precipitación de cristales de fármaco/polímero formador de película hidrofílico.
BR112018003882A2 (pt) material auxiliar para proporcionar eluição de fármaco de vasos
EP4218724A3 (en) Microstructure array for delivery of active agents
BR112013005891A2 (pt) dispositivo para fornecimento transdérmico de droga
EA201690967A1 (ru) Глазное устройство
PE20141200A1 (es) Formulacion de una capsula que comprende montelukast y levocetirizina
CR20150360A (es) Sistema de liberación transdérmica
AR098236A1 (es) Recubrimiento de alginato para tratamiento de esquejes
MX2019007389A (es) Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno.
BR102016007036A8 (pt) material de reparo de tecido derivado de pele de peixe e método de fabricação do mesmo
PH12015502556A1 (en) Modified release formulation
BR112021017878A2 (pt) Carbonato de magnésio com superfície reagida, sistema de liberação, formulação de cuidados domiciliares, métodos para preparar um carbonato de magnésio com superfície reagida e para preparar um sistema de liberação, e, uso de um carbonato de magnésio com superfície reagida e de um sistema de liberação
PE20150721A1 (es) Composicion farmaceutica que comprende gemigliptina y metformina, y metodo para su preparacion
BR112017020013A2 (pt) método para preparação de um substituto da pele, substituto da pele, substituto dérmico, enxerto, enxerto para uso, e kit para implementação do método
UA116776C2 (uk) Лікарська форма для продовженого вивільнення діючих речовин
EA201300648A1 (ru) Трансдермальная терапевтическая система (tts), содержащая ротиготин
BR112016017496A2 (pt) Composição para acelerar a penetração através da pele, preparação para administração transdérmica e preparação de emplastro de pele
MX389461B (es) Composiciones que comprenden una matriz de polisacarido para la liberacion controlada de ingredientes activos
BR112021016356A2 (pt) Composições farmacêuticas tópicas lipofílicas de apremilaste

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements